The Latin America, Middle East and Africa Digital Diabetes Management Market is expected to witness market growth of 13.9% CAGR during the forecast period (2022-2028).
Bluetooth capability has accelerated the development of healthcare apps and allowed for the creation of a single platform that houses all of a patient's pertinent health data. The OneTouch Verio Flex glucose meter, for example, will instantly sync its data with the OneTouch Reveal app, which allows patients to track their average blood glucose levels, food consumption, medication administration, and activity data. They can also create lifestyle objectives, receive warnings for low and/or high blood glucose levels, and share their data with their health care doctors directly. Similarly, the mySugr app can link to the Accu-Chek Guide, Guide Me, and Aviva Connect meters, allowing patients to enter any pertinent diet and prescription information, obtain a glucose reading analysis and estimate A1C levels.
Patients with type 1 diabetes may require more frequent tracking of their insulin intake and blood glucose levels. Diabeo and Diabetes Interactive Diary, for example, include a recording option for self-monitoring blood glucose as well as an insulin bolus calculation. The calculator is thorough, taking into account self-monitored blood glucose levels, carbohydrate intake, and physical activity through an algorithm. It also considers the insulin-to-carbohydrate ratio, correction factor, and basal insulin dose, which are all determined by the clinician. Patients who use the Accu-Chek meter to check their blood glucose levels on a regular basis can download the Accu-Chek Connect App, which syncs readings and results with the meter. Patients will be able to use the app's insulin bolus calculator and picture meal records.
In 2021, the IDF Africa Region was estimated to have 24 million individuals (20-79) living with diabetes. By 2030, this number is expected to rise to 33 million, and by 2045, to 55 million. In the IDF Africa Region, 52 million persons (20-79) have Impaired Glucose Tolerance (IGT), putting them at high risk of acquiring type 2 diabetes. By 2030, this number is expected to rise to 71 million, and by 2045, it will be 117 million. Undiagnosed diabetes affects 13 million individuals in the IDF Africa Region, accounting for 54% of the total population of diabetic adults in the region. In the IDF Africa Region in 2021, diabetes will be responsible for 416,000 fatalities.
The Brazil market dominated the LAMEA Digital Diabetes Management Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $546.4 million by 2028. The Argentina market is anticipated to grow at a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market is is expected to showcase a CAGR of 13.6% during (2022 - 2028).
Based on Type, the market is segmented into Wearables and Handheld Devices. Based on Product & Service, the market is segmented into Devices (Continuous Glucose Monitoring (CGM) Systems, Smart Glucose Meters, Smart Insulin Pens, and Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps and Obesity & Diet Management Apps), Data Management Software & Platforms, and Services. Based on End User, the market is segmented into Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, and Academic & Research Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Terumo Corporation, F. Hoffmann-La Roche Ltd., DexCom, Inc., Novo Nordisk A/S, ACON Laboratories, Inc., Bayer AG, B. Braun Melsungen AG, and Azumio, Inc.
Bluetooth capability has accelerated the development of healthcare apps and allowed for the creation of a single platform that houses all of a patient's pertinent health data. The OneTouch Verio Flex glucose meter, for example, will instantly sync its data with the OneTouch Reveal app, which allows patients to track their average blood glucose levels, food consumption, medication administration, and activity data. They can also create lifestyle objectives, receive warnings for low and/or high blood glucose levels, and share their data with their health care doctors directly. Similarly, the mySugr app can link to the Accu-Chek Guide, Guide Me, and Aviva Connect meters, allowing patients to enter any pertinent diet and prescription information, obtain a glucose reading analysis and estimate A1C levels.
Patients with type 1 diabetes may require more frequent tracking of their insulin intake and blood glucose levels. Diabeo and Diabetes Interactive Diary, for example, include a recording option for self-monitoring blood glucose as well as an insulin bolus calculation. The calculator is thorough, taking into account self-monitored blood glucose levels, carbohydrate intake, and physical activity through an algorithm. It also considers the insulin-to-carbohydrate ratio, correction factor, and basal insulin dose, which are all determined by the clinician. Patients who use the Accu-Chek meter to check their blood glucose levels on a regular basis can download the Accu-Chek Connect App, which syncs readings and results with the meter. Patients will be able to use the app's insulin bolus calculator and picture meal records.
In 2021, the IDF Africa Region was estimated to have 24 million individuals (20-79) living with diabetes. By 2030, this number is expected to rise to 33 million, and by 2045, to 55 million. In the IDF Africa Region, 52 million persons (20-79) have Impaired Glucose Tolerance (IGT), putting them at high risk of acquiring type 2 diabetes. By 2030, this number is expected to rise to 71 million, and by 2045, it will be 117 million. Undiagnosed diabetes affects 13 million individuals in the IDF Africa Region, accounting for 54% of the total population of diabetic adults in the region. In the IDF Africa Region in 2021, diabetes will be responsible for 416,000 fatalities.
The Brazil market dominated the LAMEA Digital Diabetes Management Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $546.4 million by 2028. The Argentina market is anticipated to grow at a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market is is expected to showcase a CAGR of 13.6% during (2022 - 2028).
Based on Type, the market is segmented into Wearables and Handheld Devices. Based on Product & Service, the market is segmented into Devices (Continuous Glucose Monitoring (CGM) Systems, Smart Glucose Meters, Smart Insulin Pens, and Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps and Obesity & Diet Management Apps), Data Management Software & Platforms, and Services. Based on End User, the market is segmented into Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, and Academic & Research Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Terumo Corporation, F. Hoffmann-La Roche Ltd., DexCom, Inc., Novo Nordisk A/S, ACON Laboratories, Inc., Bayer AG, B. Braun Melsungen AG, and Azumio, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Wearables
- Handheld Devices
By Product & Service
- Devices
- Continuous Glucose Monitoring (CGM) Systems
- Smart Glucose Meters
- Smart Insulin Pens
- Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
- Application
- Diabetes & Blood Glucose Tracking Apps
- Obesity & Diet Management Apps
- Data Management Software & Platforms
- Services
By End User
- Self/Home Healthcare
- Hospitals & Specialty Diabetes Clinics
- Academic & Research Institutes
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Abbott Laboratories
- Terumo Corporation
- F. Hoffmann-La Roche Ltd.
- DexCom, Inc.
- Novo Nordisk A/S
- ACON Laboratories, Inc.
- Bayer AG
- B.Braun Melsungen AG
- Azumio, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Digital Diabetes Management Market by Type
Chapter 5. LAMEA Digital Diabetes Management Market by Product & Service
Chapter 6. LAMEA Digital Diabetes Management Market by End User
Chapter 7. LAMEA Digital Diabetes Management Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- Abbott Laboratories
- Terumo Corporation
- F. Hoffmann-La Roche Ltd.
- DexCom, Inc.
- Novo Nordisk A/S
- ACON Laboratories, Inc.
- Bayer AG
- B. Braun Melsungen AG
- Azumio, Inc.
Methodology
LOADING...
